Treatment of Severe COVID-19 Infection With Remdesivir in Peritoneal Dialysis

End-stage kidney disease (ESKD) has been shown to be correlated with an increased risk of COVID-19 infection and mortality. Remdesivir is an effective non-EUA U.S. Food and Drug Administration (FDA)-approved antiviral agent for the treatment of COVID-19 in hospitalized adult and pediatric patients,...

Full description

Saved in:
Bibliographic Details
Main Authors: Ryan Geffin MD (Author), Shazia Raheem PharmD (Author), Lavannya M. Pandit MD, MS (Author), Andrew S. Hunter PharmD (Author), Michael W. Holliday MD, PhD (Author), Aditya V. Rao (Author), Maulin K. Shah MD (Author)
Format: Book
Published: SAGE Publishing, 2023-09-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available